← Back to Search

Ultrasound

LIFUP Neuromodulation for Healthy Controls

N/A
Waitlist Available
Led By Sudhakar Selvaraj, MD,PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 1 day
Treatment Varies
Follow Up 0 days
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effect of LIFUP on emotion processing, and whether it is safe to use on healthy volunteers.

Who is the study for?
This trial is for right-handed, healthy individuals who are not on drugs or psychotropic medications and have no chronic medical, psychiatric, or neurological illnesses. Women cannot be pregnant or nursing. Participants must also be comfortable with MRI scans and free from claustrophobia.
What is being tested?
The study is testing the effects of a technique called LIFUP sonication to the amygdala on emotion processing in healthy people. It aims to understand how this low-intensity focused ultrasound can stimulate or inhibit brain activity safely.
What are the potential side effects?
While the trial assesses safety, potential side effects may include discomfort at the site of sonication, headache, nausea, or other unknown risks associated with stimulating brain activity using ultrasound.

Timeline

Screening ~ 1 day
Treatment ~ Varies
Follow Up ~0 days
This trial's timeline: 1 day for screening, Varies for treatment, and 0 days for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: LIFUP sonication to the amygdalaExperimental Treatment1 Intervention

Find a Location

Logistics

Other reimbursement is provided

Other forms of reimbursement are provided for this trial.

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
347,833 Total Patients Enrolled
Sudhakar Selvaraj, MD,PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Jair Soares, MD, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

LIFUP sonication (Ultrasound) Clinical Trial Eligibility Overview. Trial Name: NCT05194332 — N/A
LIFUP sonication (Ultrasound) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05194332 — N/A
Major Depressive Disorder Research Study Groups: LIFUP sonication to the amygdala
Major Depressive Disorder Clinical Trial 2023: LIFUP sonication Highlights & Side Effects. Trial Name: NCT05194332 — N/A
~16 spots leftby Jan 2028